跳至主要内容
临床试验/EUCTR2006-005197-51-NL
EUCTR2006-005197-51-NL进行中(未招募)不适用

Accelerated growth of synchronous colorectal liver metastases: effects of neo-adjuvant therapy - Effects of neoadjuvant anti-angiogenic therapy on growth of colorectal cancer metastases

The Netherlands Cancer Institute/ Antoni van Leeuwenhoek hospital0 个研究点开始时间: 2008年6月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Histological proven primary colorectal cancer with synchronous liver metastases
  • measurable liver metastases on CT scan (RECIST), postive signal of liver metastases on FDG-PET scan
  • WHO performance scale 0-1
  • ASA category I or II
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Prior systemic treatment for advanced disease
  • prior treatment with anti-angiogenic drugs
  • contra-indications for systemic therapy with bevacizumab
  • concurrent severe or uncontrolled disease
  • diabetes mellitus

研究者

发起方
The Netherlands Cancer Institute/ Antoni van Leeuwenhoek hospital

相似试验